Delivery Order SPE2DB20D3104-SPE2DB22FV6Q0

Award Date 4/27/22
Potential Completion Date 4/28/22
Potential Value $3.1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Xarelto 20 mg tablets. The order, valued at $15,029.27, has a completion date of September 3, 2021. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025. This IDC...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Xarelto 20 mg tablets. The contract, valued at $7,043.14, has an ultimate completion date of August 10, 2021. AmerisourceBergen is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Xarelto 20 mg tablets. The $1,985.81 fixed-price contract has a completion date of February 23, 2024. Amerisourcebergen is the child company of the parent firm Cencora, Inc., which also does business as Amerisourcebergen. The contract is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Xarelto 20 mg tablets. The $34,851.81 firm-fixed-price contract has a completion date of September 16, 2022 and was awarded on September 15, 2022. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as the primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Xarelto 20 mg tablets. The $13,464.48 firm-fixed-price contract has a completion date of November 2, 2022. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical for the provision of a comprehensive range of pharmaceutical products...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XARELTO 20 MG tablets. The $17,748.26 firm fixed-price contract has an ultimate completion date of November 3, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Xarelto 20 mg tablets. The contract, valued at $4,526.99, is a firm fixed-price delivery order with a completion date of February 7, 2023. Amerisourcebergen is a major pharmaceutical distributor and has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00, which serves as the primary vehicle for...
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Xarelto 20 mg tablets. The $15,620.37 firm fixed-price contract has a completion date of March 11, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical for a comprehensive range of pharmaceutical products and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of XARELTO 20 MG TABLET 90S. The contract, valued at $18,332.53, is a firm fixed-price delivery order with a completion date of March 23, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,751.14, is for the delivery of Xarelto 20 mg tablets. The contract is a firm fixed-price delivery order with an ultimate completion date of January 11, 2024. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit pharmaceutical distribution company. Amerisourcebergen holds a significant...
  • SPE2DB20D3104
    Indefinite Delivery Contract
  • SPE2DB20D3104-SPE2DB22FV6Q0
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Xarelto 20 mg tablets. The $3,115.92 firm fixed-price contract has an ultimate completion date of April 28, 2022. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC serves as the primary vehicle for AmerisourceBergen to deliver a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition.

Generated 2/27/25, 10:23 AM